AITL is characterized by specific epigenetic mutations such as TET2, DNMT3A, IDH2, and RHOA, which have been identified as genes which regulate functionality in the sequence of events required for DNA demethylation (162, 163). The gene discussed is IDH2; the disease is angioimmunoblastic T-cell lymphoma.